Insider Trading26 Sept 2026, 03:32 pm
Genpharmasec Ltd Closes Trading Window for Insider Trading
AI Summary
Genpharmasec Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from October 1, 2026, until 48 hours after the declaration of the un-audited financial results for the quarter and half-year ended September 30, 2026. Promoters, directors, key managerial persons, designated persons, and their immediate relatives are prohibited from trading during this period. The company will announce the date of the board meeting to approve these financial results in due course.
Key Highlights
- Trading window closed from October 1, 2026.
- Closure is for dealing in company securities by insiders.
- Period extends 48 hours post Q2 FY27 results declaration.
- Aims to prevent insider trading as per SEBI regulations.
- Board meeting date for results approval to be announced later.
Price Impact
More from GENPHARMA